Expensify, Inc.

For the period ended Sep 30, 2025. Filed Nov 6, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Nov 6, 2025

EXFY$1.72-7.0%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Statements of Changes in Stockholders’ Equity

Preferred stock · Common stock · Additional paid-in capital · Accumulated deficit · Total stockholders' equity
Shares · Amount · Shares · Amount
Balance at June 30, 2025	—	$—	92,647,210	$9	$294,591	$(162,785)	$131,815
Issuance of common stock on exercise of stock options	—	—	260,962	—	198	—	198
Issuance of restricted stock units	—	—	2,128	—	5	—	5
Settlement of liability-classified restricted common shares	—	—	237,573	—	—	—	—
Issuance of common stock under Matching Plan	—	—	1,267,158	—	1,741	—	1,741
Issuance of common stock in connection with restricted stock units vesting	—	—	196,268	—	—	—	—
Repurchase and retirement of common stock	—	—	(1,579,763)	—	(3,031)	—	(3,031)
Stock-based compensation	—	—	—	—	7,247	—	7,247
Net loss	—	—	—	—	—	(2,315)	(2,315)
Balance at September 30, 2025	—	$—	93,031,536	$9	$300,751	$(165,100)	$135,660

See accompanying notes to Condensed Consolidated Financial Statements.

Preferred stock · Common stock · Additional paid-in capital · Accumulated deficit · Total stockholders' equity
Shares · Amount · Shares · Amount
Balance at June 30, 2024	—	$—	88,194,690	$9	$261,309	$(147,318)	$114,000
Issuance of common stock upon exercise of stock options	—	—	250,388	—	250	—	250
Vesting of early exercised stock options	—	—	—	—	94	—	94
Issuance of restricted stock units	—	—	11,666	—	18	—	18
Repurchases of early exercised stock options	—	—	(2,520)	—	—	—	—
Issuance of common stock under Matching Plan	—	—	911,645	—	896	—	896
Issuance of common stock in connection with restricted stock units vesting	—	—	206,745	—	—	—	—
Repurchase and retirement of common stock	—	—	(645,938)	—	(1,510)	—	(1,510)
Stock-based compensation	—	—	—	—	8,384	—	8,384
Net loss	—	—	—	—	—	(2,198)	(2,198)
Balance at September 30, 2024	—	$—	88,926,676	$9	$269,441	$(149,516)	$119,934

See accompanying notes to Condensed Consolidated Financial Statements.

Preferred stock · Common stock · Additional paid-in capital · Accumulated deficit · Total stockholders' equity
Shares · Amount · Shares · Amount
Balance at December 31, 2024	—	$—	91,376,765	$9	$279,062	$(150,828)	$128,243
Issuance of common stock on exercise of stock options	—	—	357,044	—	315	—	315
Vesting of early exercised stock options	—	—	—	—	113	—	113
Issuance of restricted stock units	—	—	8,600	—	28	—	28
Settlement of liability-classified restricted common shares	—	—	382,393	—	—	—	—
Issuance of common stock under Matching Plan	—	—	2,950,902	—	4,351	—	4,351
Issuance of common stock in connection with restricted stock units vesting	—	—	820,931	—	—	—	—
Repurchase and retirement of common stock	—	—	(2,865,099)	—	(6,057)	—	(6,057)
Stock-based compensation	—	—	—	—	22,939	—	22,939
Net loss	—	—	—	—	—	(14,272)	(14,272)
Balance at September 30, 2025	—	$—	93,031,536	$9	$300,751	$(165,100)	$135,660

See accompanying notes to Condensed Consolidated Financial Statements.

Preferred stock · Common stock · Additional paid-in capital · Accumulated deficit · Total stockholders' equity
Shares · Amount · Shares · Amount
Balance at December 31, 2023	—	$—	85,225,328	$8	$241,509	$(140,773)	$100,744
Issuance of common stock upon exercise of stock options	—	—	306,917	—	303	—	303
Vesting of early exercised stock options	—	—	—	—	337	—	337
Issuance of restricted stock units	—	—	27,925	—	53	—	53
Repurchase of early exercised stock options	—	—	(32,954)	—	—	—	—
Issuance of common stock under Matching Plan	—	—	3,364,621	1	2,899	—	2,900
Issuance of common stock in connection with restricted stock units vesting	—	—	680,777	—	—	—	—
Repurchase and retirement of common stock	—	—	(645,938)	—	(1,510)	—	(1,510)
Stock-based compensation	—	—	—	—	25,850	—	25,850
Net loss	—	—	—	—	—	(8,743)	(8,743)
Balance at September 30, 2024	—	$—	88,926,676	$9	$269,441	$(149,516)	$119,934

See accompanying notes to Condensed Consolidated Financial Statements.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.